{"id":"W3014334390","doi":"10.1111/jth.14813","title":"Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein‐Jr phase 3 dose‐exposure‐response evaluation","year":2020,"lang":"en","type":"article","venue":"Journal of Thrombosis and Haemostasis","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University; University of Alberta; McMaster Children's Hospital","funders":"Janssen Research and Development; Bayer","keywords":"Rivaroxaban; Medicine; Dosing; Cmax; Adverse effect; Tolerability; Pharmacokinetics; Population; Anesthesia; Area under the curve; Internal medicine; Warfarin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00368722,0.001720088,0.002533876,0.0004826063,0.0003578255,0.001437351,0.000735166,0.001221285,0.003161846],"category_scores_gemma":[0.002272656,0.0006697959,0.002926326,0.0005646492,0.000752451,0.001090708,0.0003421272,0.003412951,0.0006912061],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009966714,"about_ca_system_score_gemma":0.002175165,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001079749,"about_ca_topic_score_gemma":0.002779454,"domain_scores_codex":[0.9985479,0.0008369991,0.00009819816,0.0001543322,0.0001668258,0.0001957888],"domain_scores_gemma":[0.9985838,0.0003693232,0.0004962962,0.0001404445,0.00009869347,0.0003114849],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6429593,0.0432744,0.0130259,0.002514909,0.008562217,0.0004256846,0.000736065,0.005393717,0.02094561,0.001551689,0.008874419,0.2517361],"study_design_scores_gemma":[0.7000627,0.250084,0.02413792,0.0002736246,0.003271655,0.001078344,0.0001501501,0.00198193,0.003391107,0.000549866,0.01492678,0.00009204484],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9723922,0.01605628,0.002247865,0.001172939,0.0001869069,0.002671793,0.002162748,0.000209697,0.002899582],"genre_scores_gemma":[0.9558477,0.02232515,0.007850359,0.003074532,0.0002982195,0.004318771,0.003048445,0.000191369,0.003045598],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00368722,"threshold_uncertainty_score":0.01950008,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1868536090917949,"score_gpt":0.4043901099778911,"score_spread":0.2175365008860962,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}